- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: coagulation factor VIIa [recombinant]-jncw
Total 1494 results
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderUnited Kingdom
-
Leiden University Medical CenterNovo Nordisk A/S; University of Oxford; Herlev Hospital; VU University of AmsterdamCompletedPost Partum HemorrhageNetherlands
-
Eio Biomedical Ltd.CompletedReduction of Postoperative AdhesionsLithuania
-
Baxalta now part of ShireCompletedProthrombin Complex Factor DeficiencyHungary, Austria
-
Genentech, Inc.Completed
-
Emory UniversityOctapharmaRecruitingHemophilia AUnited States, Germany
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, United Kingdom, Spain, Germany, Canada, Puerto Rico, Italy, Sweden, Austria
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SCompletedHealthy | HaemostasisUnited States
-
Massachusetts General HospitalBaxter Healthcare CorporationCompletedDehydration | Mass Casualty IncidentUnited States
-
Medical University of ViennaCompleted
-
The Hospital for Sick ChildrenCompleted
-
Lund UniversityWithdrawn
-
Prothya BiosolutionsCompletedHemophilia BNetherlands
-
Second Affiliated Hospital, School of Medicine,...RecruitingInflammation | Cerebral Edema | Coagulation and Hemorrhagic DisordersChina
-
Grifols Therapeutics LLCGrifols Biologicals, LLCTerminatedHemophilia A, CongenitalUnited States, Spain, Italy, India, Canada, Russian Federation
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia BSweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
-
Novo Nordisk A/SEnrolling by invitationCongenital Bleeding Disorder | Congenital FXIII DeficiencyJapan
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Belarus, Bulgaria, Hungary, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom
-
University of VirginiaNot yet recruiting
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencySpain, United States, Canada, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom, Israel, United States
-
OctapharmaCompletedSevere Hemophilia ABulgaria, Poland, Hungary, Romania, Russian Federation
-
Janssen Research & Development, LLCCompleted
-
IRCCS Policlinico S. MatteoCompletedIntracerebral HemorrhageItaly
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...Active, not recruitingHemophilia AUnited States, Spain, Hungary, Italy, Germany, Austria, France
-
Novo Nordisk A/STerminatedInflammation | Ulcerative ColitisPoland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
-
Medexus Pharma, Inc.TerminatedHemophilia BUnited States, United Kingdom, India
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AAustralia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
-
New York Presbyterian HospitalManchester University NHS Foundation TrustTerminated
-
Medexus Pharma, Inc.CompletedHemophilia BTurkey, Brazil, Georgia, Moldova, Republic of, South Africa, Ukraine
-
University of UtahSheila B. Terry Memorial Research FundTerminated
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | ThromboembolismUnited States
-
Ain Shams Maternity HospitalUnknownUric Acid and Hypertension in PregnancyEgypt
-
Semmelweis UniversityCompletedBlood Loss, Postoperative | Liver Transplant | Hemostatic DisorderHungary
-
Grifols Biologicals, LLCActive, not recruitingVon Willebrand Disease
-
Children's Oncology GroupNational Cancer Institute (NCI)WithdrawnMalignant Neoplasm | Gastrointestinal Mucositis
-
Baxalta now part of ShireCompletedHemophilia BPoland, United Kingdom, Spain, Bulgaria, Romania, Japan, Russian Federation, Brazil, Chile, Sweden, Colombia, Ukraine, Argentina, Czechia
-
Merck KGaA, Darmstadt, GermanyCompletedInfertility Implantation Failure
-
Merck KGaA, Darmstadt, GermanyCompletedInfertility Implantation Failure
-
CanSino Biologics Inc.Jiangsu Province Centers for Disease Control and Prevention; Beijing Institute...Completed
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
CanSino Biologics Inc.Jiangsu Province Centers for Disease Control and PreventionCompleted
-
Beijing Tongren HospitalRecruiting
-
Martin, PaulNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditionsUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan Biovitrum; Syntonix Pharmaceuticals, Inc.Completed